Tag: Orange Book

Patent Litigation and Generic Entry: How Paragraph IV Drives Affordable Medicines

Paragraph IV under the Hatch-Waxman Act lets generic drug makers challenge brand patents to bring cheaper medicines to market faster. Learn how it works, why it matters, and how it saves billions for patients.